According to a new report, published by KBV research, The Global Cell Freezing Media Market size is expected to reach $283.7 million by 2030, rising at a market growth of 9.7% CAGR during the forecast period.
The DMSO segment is leading the Global Cell Freezing Media Market by Product in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $147.2 Million by 2030. The segment's growth results from the acknowledged gold standard from generations employing DMSO in conventional cryopreservation for halting cell metabolism. Due to its solvation and aprotic characteristics, DMSO is the main player in cryobiology. Its highest market share has also been influenced by the numerous applications of DMSO-based cell freezing medium.
The Cancer Cell Lines segment is showcasing a CAGR of 10.4% during (2023 - 2030). Numerous studies have been conducted in various fields, such as cancer, due to the increasing number of life-threatening diseases and the need for cutting-edge treatments. As a result of ongoing research efforts for better healthcare, cell freezing media has also seen a sizable market presence for cancer cell lines that will continue to develop gradually in the years to come.
The Pharmaceutical & Biotechnological Companies segment acquired the maximum revenue share in the Global Cell Freezing Media Market by End-use in 2022 thereby, achieving a market value of $132.3 Million by 2030. The segment's expansion is ascribed to the biopharmaceuticals' ongoing development and commercial success, as well as the expanding product lines of the main pharmaceutical corporations. Its acceptance has been sparked by the cell preservation medium's superior protection and preservation as well as its cost-effectiveness in comparison to standard freezing techniques. The constant use of such consumables during the research, development, as well as commercial stages, is projected to support market expansion.
The North America region dominated the Global Cell Freezing Media Market by Region in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $104.3 Million by 2030. The Europe market is showcasing of 9.2% during (2023 - 2030). Additionally, The Asia Pacific market would display a CAGR of 10.5% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/cell-freezing-media-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Thermo Fisher Scientific, Inc., Merck KGaA, Sartorius AG, Bio-Techne Corporation, HiMedia Laboratories Pvt. Ltd., BPS Bioscience, Inc., BioLife Solutions, Inc., PromoCell GmbH, Capricorn Scientific GmbH, and Cell Applications, Inc.
By Product
By Application
By End-Use
By Geography
Companies Profiled
Unique Offerings 
